Navigation Links
Man and mouse share genome structures

In the most detailed large-scale study to date of the proteins that package DNA, researchers have mapped a family of switches that turn genes on and off. Their findings may help scientists understand regulatory mechanisms underlying cancer and human development.

The research team includes first author Bradley Bernstein, recipient of a Howard Hughes Medical Institute (HHMI) physician postdoctoral fellowship who works in the Harvard University laboratory of HHMI investigator Stuart L. Schreiber. Other co-authors are from the Broad Institute of MIT and Harvard, and Affymetrix. Their findings are published in the January 28, 2005 issue of Cell.

"Now that the human genome has been sequenced, it is vital to learn how the genome is translated to make living cells and organisms, and how we can use that information to improve human health," said Bernstein, who is an instructor of pathology at Brigham & Women's Hospital and Harvard Medical School. "Every one of our cells has the same genome, yet is completely different. Muscle cells are different from neurons. They are different because different genes are on."

Many scientists believe changes in the regulatory scaffolding surrounding the genome may be as important as changes in the genome itself in causing diseases such as cancer.

This regulatory structure, called chromatin, is a key regulator of gene expression in healthy and diseased cells, Bernstein said. Chromatin is composed of DNA spooled around bundles of histone proteins, and resembles a chain of beads which is then compressed into a working chromosome. Chemical tags placed on the histones alter the way chromatin is organized, thus allowing the right combination of genes to be turned on.

In their study, the researchers analyzed the chromatin structure of the two shortest human chromosomes, numbers 21 and 22, containing about two percent of the human genome. They also sampled additional regions in both the human and mouse geno
'"/>

Source:Howard Hugues Medical Institute


Page: 1 2 3

Related biology news :

1. Genome-wide mouse study yields link to human leukemia
2. Report that delayed motherhood decreases life expectancy of mouse offspring
3. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
4. Stem cells in bone marrow replenish mouse ovaries
5. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
6. Researchers extend mouse lifespan by protecting against free radicals
7. Gene therapy advance treats hemophilia in mouse models
8. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
9. New technique could alter field of mouse genetics
10. Building a better mouse model of lung cancer: FHIT counts
11. Chemical compound inhibits tumor growth, size in new mouse study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Man and mouse share genome structures

(Date:11/4/2009).... 20 Aware, Inc. (Nasdaq...ogy and biometrics software, today reported financ... 30, 2009. ,, Michael Tzannes, Aware,s Chairm...ay, we announced an agreement to sell our DSL and ...less semiconductor company being spun out of Infin...
(Date:11/4/2009)...PRNewswire/ -- Global Rainmakers, Inc., an intelle...D laboratory, today announced that the company has...vely commercialize its suite of technologies desig...ferings. ,, During the past four years, the com...lop and deploy a series of core--but expandable--t...
(Date:11/3/2009)...4, 2009 -- The world,s greatest wines are the res...man input, and something called the "terroir" -- a...d climate. , Experts will discuss terroir with...nesday, Nov. 4 in Pittsburgh. "Terroir: Winegrape...rts at the 2009 Annual Meetings of the American So...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Great wines come from great soils 2Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 1Polaroid 28R 29 and The Breast Cancer Research Foundation 28R 29 Print Pink 58554 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 1Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 2Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 3Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 4Intarcia Therapeutics Inc Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabe 14300 5Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 1Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 2Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 3Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 4Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 5
...egulates blood pressure in response to daily stres...ople whose pressure is out of control. , "Resear...ressure is not controlled despite the best efforts...gory Harshfield, director of the Georgia Preventio..."We are trying to identify the mechanisms through ...
...es in the Amazon will survive even grim scenarios ... could suffer extinction rates of up to 50 percent... the Aug. 12 issue of the journal Proceedings of ...ill natural systems prove to be as they weather th...obal change? The debate is on between proponents o...
... bloodhound, Sentry the newest in an elite group ...own in demanding and rugged environments has help...bservation sites of a pioneering seafloor laborato...ccessful selection of the two sites is a crucial s...e and below the seafloor on the Juan de Fuca Plate...
Other Biology News:Blood pressure response to daily stress provides clues for better hypertension treatment 2Blood pressure response to daily stress provides clues for better hypertension treatment 3Blood pressure response to daily stress provides clues for better hypertension treatment 4Blood pressure response to daily stress provides clues for better hypertension treatment 5Blood pressure response to daily stress provides clues for better hypertension treatment 6Extinction most likely for rare trees in the Amazon rainforest 2New robot scouts best locations for components of undersea lab 2New robot scouts best locations for components of undersea lab 3
(Date:11/6/2009)...Newswire/ -- Calbiotech, Inc. announced today that...esearch (SBIR) Phase I contract by the U.S. Army M...of the agreement, Calbiotech will develop analyte ...ue virus. ,, Dengue virus is a mosquito-born...tary forces deployed to tropical areas of the worl...
(Date:11/5/2009)...wire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) t... quarter ended September 30, 2009. GenVec reported...the three months ended September 30, 2009 compared...n the comparable quarter of 2008. For the nine mon...s $14.1 million ($0.15 per share), compared to a n...
(Date:11/5/2009)...mber 5, 2009 at 4:30 p.m. Eastern Time , BOTH.../ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" o...naudited financial results for the third quarter a...ed the Company,s highlights for the third quarter ...reflect the operations of OncoGenex Technologies I...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: S...e receptor-based technologies to discover novel fl...dient supply industries, today provided a corporat...ird quarter ended September 30, 2009. Revenues we...pared to $4.0 million for the third quarter of 200...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...Oct. 29 Aloka Co., Ltd., the Innovator in,Ultraso...troduction of two,ultrasound systems with dedicate...ing, the ProSound Alpha 10 and the ProSound Alpha ...ociation, at the Orange County,Convention Center i...und Alpha 7 and the Alpha 10 incorporate all of th...
...s Presented at American Academy of Pediatrics Nati...hibition, SAN FRANCISCO and EAST NORRITON, Pa., O...icine, announced today that findings from,a precli...Academy of,Pediatrics (AAP) National Conference an...n Neo-Bladder Augment(TM) to restore bladder funct...
...K, October 29 XTL Biopharmaceuticals,Ltd. (NASDAQ...t Ron Bentsur,the Company,s Chief Executive Office...dman & Renshaw 9th Annual Health Care Conference. ...y including a discussion of,Bicifadine, the Compan... of,neuropathic pain. Mr. Bentsur,s presentation w...
Other Biology Technology:ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 2ALOKA to Introduce New 'ProSound' Diagnostic Ultrasound Systems at the Scientific Session 2007 of American Heart Association, 4th to 7th of November 2007 in Orlando, Florida 3Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3XTL Biopharmaceuticals to Present at the Rodman & Renshaw 9th Annual Health Care Conference 2
...500-MS LC Ion Trap is the instrument of choice for... reliability and productivity are essential.,...demanding LC/MS/MS applications. The system sensit...58;ect the ion trap technologys inherent advantage...
Benchtop Ductless Exhaust Fume Hood from Terra Universal, Inc.
Distillation Hood from Terra Universal, Inc.
Telomerase Gel-based assay Assay Kit, TRAPeze from CHEMICON
Biology Products: